From: Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer
Variables | Disease-free survival | Overall survival | ||||
---|---|---|---|---|---|---|
 | p value |  | p value |  | ||
 | Univariate | Multivariate | HR a (95% CI) | Univariate | Multivariate | HR a (95% CI) |
Age | 0.037 | 0.205b | 1.53 (0.79 - 2.96)b | 0.138 | Â | Â |
 |  | 0.278c | 1.44 (0.75 - 2.78)c |  |  |  |
Tumor size | 0.862 | Â | Â | 0.563 | Â | Â |
Lymph node | 0.003 | 0.003b | 2.70 (1.40 - 5.23)b | 0.002 | 0.002b | 2.81 (1.46 - 5.42)b |
 |  | 0.008c | 2.41 (1.25 - 4.64)c |  | 0.005c | 2.57 (1.34 - 4.93)c |
ER | 0.0008 | 0.004b | 3.79 (1.53 - 9.38)b | 0.002 | 0.004b | 3.52 (1.50 - 8.23)b |
PR | 0.109 | Â | Â | 0.168 | Â | Â |
HER2/neu | 0.997 | Â | Â | 0.619 | Â | Â |
Grade | 0.183 | Â | Â | 0.318 | Â | Â |
ECD | 0.0002 | 0.214b | 1.62 (0.76 - 3.47)b | 0.005 | 0.451b | 1.34 (0.62 - 2.90)b |
 |  | 0.097c | 1.89 (0.89 - 3.99)c |  | 0.341c | 1.45 (0.68 - 3.09)c |
Chemotherapy* | 0.122 | Â | Â | 0.224 | Â | Â |
Radiation therapy | 0.418 | Â | Â | 0.859 | Â | Â |
Hormone therapy | 0.001 | 0.011c | 0.31 (0.13 - 0.77)c | 0.001 | 0.004c | 0.27 (0.11 - 0.65)c |